Activated T Lymphocytes in Type 2 Diabetes: Implications From in Vitro Studies

E-ISSN： 1873-5592|4|6|493-503

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.6, 2003-01, pp. : 493-503

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro and in silico Studies of Mangiferin from Aphloia theiformis on Key Enzymes Linked to Diabetes Type 2 and Associated Complications

Medicinal Chemistry, Vol. 13, Iss. 7, 2017-10 ,pp. : 633-640

Bentham Science Publishers

Access to resources Recommend Favorite

AMP-Activated Protein Kinase and Type 2 Diabetes

Current Medicinal Chemistry, Vol. 13, Iss. 5, 2006-03 ,pp. : 583-589

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 Diabetes

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 2, 2002-07 ,pp. : 119-127

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of cytosolic phospholipase A 2 in human T-lymphocytes involves inhibitor- B and mitogen-activated protein kinases

By Burgermeister E. Endl J. Scheuer W.V.

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 169-180

Elsevier

Access to resources Recommend Favorite

Sex Differences in Type-2 Diabetes: Implications for Cardiovascular Risk Management

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1471-1476

Bentham Science Publishers

Access to resources Recommend Favorite